Latest Regulatory News

Corazon Mining has kicked off its first diamond drilling program at the Two Pools Gold Project in Western Australia, aiming to unlock the structural secrets of this high-grade gold system. Initial assay results are expected soon, potentially setting the stage for a major resource expansion.

Eve Health Group is advancing its proprietary reformulation platform with two fast-onset products launched under Australia's SAS-B pathway, targeting large underserved markets in women's and men's health. The company’s capital-light, partner-led model aims for rapid revenue growth post-ARTG registration.

Reach Resources Limited has announced a pro-rata entitlement issue aiming to raise up to $3.15 million to fund exploration and working capital, with key directors and the CEO committing to participate.

Atomo Diagnostics has responded to an ASX price query following unusual trading activity, denying any undisclosed price-sensitive information while acknowledging a related FDA update involving Lumos Diagnostics.

Klevo Rewards’ subsidiary Fly Wallet has engaged top-tier law firm Hamilton Locke to establish the legal framework for its upcoming KLV stablecoin, aiming to ensure regulatory compliance in Australia’s evolving digital asset landscape.

APA Group has finalised the sale of its 20% stake in the Allgas Network, receiving $62 million as part of Stonepeak's full acquisition of GDI. This move aligns with APA's strategy to streamline operations and focus on growth.

ActivEX Limited has completed a $393,505 share placement, issuing nearly 20 million shares at 2 cents each, with funds earmarked for advancing exploration projects and supporting working capital.

KMD Brands Limited has announced plans for a capital raise via placement and AREO, coinciding with its upcoming half-year financial results. The company has requested a trading halt as it finalises the terms.

Greenwing Resources has launched a Pre-Feasibility Study to refine its plan for restarting mining at Que River, Tasmania, while exploring a novel data infrastructure opportunity on site.

Emu NL has announced a pro-rata non-renounceable rights issue aiming to raise approximately $3.67 million, offering new shares with free attaching options to eligible shareholders. The capital raise will primarily fund exploration activities at its Queensland projects and strengthen working capital.

Brazilian Rare Earths Limited has secured a key Trial Mining Licence for its Monte Alto project, marking a significant step toward commercial rare earths production in Brazil.

Clarity Pharmaceuticals has signed a significant manufacturing supply agreement with Theragenics to produce copper-64, a key isotope for its upcoming prostate cancer diagnostic, Cu-SAR-bisPSMA. This deal strengthens Clarity’s US supply network ahead of anticipated FDA approval and commercial launch.